Record Quarterly Revenue of $126.5 Million, Up 28% Year-Over-Year
Annualized Recurring Revenue of $474.9 Million, Up 25% Year-Over-Year
Net Revenue Retention Rate of 116%
Net Income of $420.3 Million
Adjusted EBITDA of $41.7 Million, Up 39% Year-Over-Year
BOISE, Idaho — February 19, 2025 — Clearwater Analytics Holdings, Inc. (NYSE: CWAN) (“Clearwater Analytics” or the “Company”), a leading worldwide provider of SaaS-based investment management, accounting, reporting, and analytics solutions, today announced its financial results for the quarter ended December 31, 2024.
| Fourth Quarter 2024 | Full Year 2024 | ||
| Revenue | $126.5 million | $451.8 million | |
| Year-over-Year Revenue Growth % | 27.7% | 22.7% | |
| Annualized Recurring Revenue (ARR)1 | $474.9 million | ||
| Year-over-Year ARR Growth % | 25.3% | ||
| Net Income | $420.3 million | $427.6 million | |
| Net Income Margin % | 332.3% | 94.6% | |
| Adjusted EBITDA | $41.7 million | $145.7 million | |
| Adjusted EBITDA Margin % | 33.0% | 32.2% |
1ARR is a point in time metric, therefore fourth quarter 2024 and full year 2024 results are the same.
“Q4 2024 has been nothing short of extraordinary for Clearwater Analytics, as we achieved record revenue of $126.5 million and a record net revenue retention rate of 116%. Non-GAAP gross margin grew 170 bps for the year and adjusted EBITDA grew 350 bps for the year. All these metrics are entirely consistent with our plans and the expectations we set during our Investor Day – our execution has allowed us to meet and exceed those goals meaningfully earlier than forecast. These results reflect the effectiveness of our strategies and the relentless dedication of our team, who consistently exceed our clients’ evolving expectations. We continue to invest aggressively in R&D, including Generative AI, to stay ahead of the market and deliver impactful solutions that our clients value. We continue to see significant growth opportunities in both new logo and back-to-base sales in North America and the international markets, particularly in Europe and Asia, where our expertise and technology position us for expansion. We’re confident that our scalable platform will adeptly meet the rising demand from asset owners and managers in these regions,” said Sandeep Sahai, CEO at Clearwater Analytics. “Our announced acquisition of Enfusion is a game changer. This pivotal milestone will broaden our horizons for growth and allow us to extend additional products to our current clients, while enabling us to offer a comprehensive front-to-back platform that will cover the entire investment lifecycle. We’re scaling with a clear vision, excited about our journey, and committed to delivering exceptional value to our clients, employees, and shareholders.”
Fourth Quarter 2024 Financial Results Summary
Fourth Quarter 2024 Key Metrics Summary
ARR is calculated at the end of a period by dividing the recurring revenue in the last month of such period by the number of days in the month and multiplying by 365.
Gross revenue retention rate represents annual contract value (“ACV”) at the beginning of the 12-month period ended on the reporting date less client attrition over the prior 12-month period, divided by ACV at the beginning of the 12-month period, expressed as a percentage. ACV is comprised of annualized recurring revenue plus contracted-not-billed revenue, which represents the estimated annual contracted revenue for new and existing client opportunities prior to revenue recognition.
Net revenue retention rate is the percentage of recurring revenue from clients on the platform for 12 months and includes changes from the addition, removal, or value of assets on our platform, contractual changes that have an impact to annualized recurring revenues and lost revenue from client attrition.
Recent Business Highlights
First Quarter and Full Year 2025 Guidance
| First Quarter 2025 | Full Year 2025 | ||
| Revenue | $125 million | $535.5 million to $542 million | |
| Year-over-Year Growth % | ~22% | ~19% to 20% | |
| Adjusted EBITDA | $41.5 million | $182 million to $185 million | |
| Adjusted EBITDA Margin % | ~33% | ~34% | |
| Total equity-based compensation expense and related payroll taxes | ~$106 million | ||
| Depreciation and Amortization | ~$13 million | ||
| Non-GAAP effective tax rate | 25% | ||
| Diluted non-GAAP share count | ~263 million |
*This guidance assumes no effect from the proposed Enfusion acquisition.
Certain components of the guidance given above are provided on a non-GAAP basis only without providing a reconciliation to guidance provided on a GAAP basis. Information is presented in this manner because the preparation of such a reconciliation could not be accomplished without “unreasonable efforts.” The Company does not have access to certain information that would be necessary to provide such a reconciliation, including non-recurring items that are not indicative of the Company’s ongoing operations. The Company does not believe that this information is likely to be significant to an assessment of the Company’s ongoing operations.
Conference Call Details
Clearwater Analytics will hold a conference call and webcast on February 19, 2025, at 5:00 p.m. Eastern time to discuss fourth quarter and full year 2024 financial results, provide a general business update, and respond to analyst questions.
A live webcast of the call will also be available on the Company’s investor relations website. Please visit investors.clearwateranalytics.com at least fifteen minutes prior to the start of the event to register, download and install any necessary audio software.
If you are unable to participate live, a replay of the webcast will be available following the conference call on the Company’s investor relations website, along with the earnings press release, and related financial tables.
About Clearwater Analytics
Clearwater Analytics (NYSE: CWAN), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant architecture, Clearwater offers award-winning investment portfolio planning, performance reporting, data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and governments use Clearwater’s trusted data to drive efficient, scalable investing on more than $8.8 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found at clearwateranalytics.com.
Investor Contact:
Joon Park | +1 415-906-9242 | investors@clearwateranalytics.com
Media Contact:
Claudia Cahill | +1 703-728-1221 | press@clearwateranalytics.com
Use of non-GAAP Information
This press release contains certain non-GAAP measures, including non-GAAP gross profit, non-GAAP gross margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per basic and diluted share, non-GAAP effective tax rate, diluted non-GAAP share count and free cash flow.
The non-GAAP measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similar measures presented by other companies. However, the Company believes that this non-GAAP information is useful as an additional means for investors to evaluate its operating performance, when reviewed in conjunction with its GAAP financial statements. These measures should not be considered in isolation or as a substitute for measures prepared in accordance with GAAP, and because these amounts are not determined in accordance with GAAP, they should not be used exclusively in evaluating the Company’s business and operations. In addition, undue reliance should not be placed upon non-GAAP or operating information because this information is neither standardized across companies nor subjected to the same control activities and audit procedures that produce the Company’s GAAP financial results.
The Company’s non-GAAP statement of operations measures, including non-GAAP gross profit, non-GAAP gross margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per basic and diluted share, non-GAAP effective tax rate, diluted non-GAAP share count and free cash flow, are adjusted to exclude the impact of certain costs, expenses, gains and losses and other specified items that management believes are not indicative of its ongoing operations. These adjusted measures exclude the impact of share-based compensation and eliminate potential differences in results of operations between periods caused by factors such as financing and capital structures, taxation positions or regimes, restructuring, transaction expenses, impairment and other charges. Please refer to the reconciliations of these measures below to what the Company believes are the most directly comparable measures evaluated in accordance with GAAP.
Use of Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to management. Forward-looking statements include information concerning the timing of the consummation of acquisition of Enfusion and the ability to satisfy closing conditions, the Company’s possible or assumed future results of operations, business strategies, technology developments, financing and investment plans, dividend policy, competitive position, industry, economic and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “aim,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would” or similar expressions and the negatives of those terms, but are not the exclusive means of identifying such statements.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control, that may cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties may cause actual results to differ materially from Clearwater Analytics’ current expectations and include, but are not limited to, the Company’s ability to successfully close the acquisition of Enfusion, the Company’s ability to successfully integrate the operations and technology of Enfusion with those of the Company, retain and incentivize the employees of Enfusion following the close of the acquisition, retain Enfusion’s clients, repay debt to be incurred in connection with the Enfusion acquisition and meet financial covenants to be imposed in connection with such debt, risks that cost savings, synergies and growth from the proposed Enfusion acquisition may not be fully realized or may take longer to realize than expected, the Company’s ability to keep pace with rapid technological change and market developments, including artificial intelligence, competitors in its industry, the possibility that market volatility, a downturn in economic conditions or other factors may cause negative trends or fluctuations in the value of the assets on the Company’s platform, the Company’s ability to manage growth, the Company’s ability to attract and retain skilled employees, the possibility that the Company’s solutions fail to perform properly, disruptions and failures in the Company’s and third parties’ computer equipment, cloud-based services, electronic delivery systems, networks and telecommunications systems and infrastructure, the failure to protect the Company, its customers’ and/or its vendors’ confidential information and/or intellectual property, claims of infringement of others’ intellectual property, factors related to the Company’s ownership structure as well as other risks and uncertainties detailed in Clearwater Analytics’ periodic public filings with the U.S. Securities and Exchange Commission (the “SEC”), including but not limited to those discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 29, 2024, those discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 that will be filed following this earnings release, and in other periodic reports the Company subsequently files with the SEC. These filings are available at www.sec.gov and on the Company’s website. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent management’s beliefs and assumptions only as of the date of this press release and should not be relied upon as representing the Company’s expectations or beliefs as of any date subsequent to the time they are made. The Company does not undertake to and specifically declines any obligation to update any forward-looking statements that may be made from time to time by or on behalf of the Company.
Clearwater Analytics Holdings, Inc.
Consolidated Balance Sheets
(In thousands, except share amounts and per share amounts, unaudited)
| December 31, | December 31, | ||
| 2024 | 2023 | ||
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | $ 177,350 | $ 221,765 | |
| Short-term investments | 78,139 | 74,457 | |
| Accounts receivable, net | 106,151 | 92,091 | |
| Prepaid expenses and other current assets | 23,006 | 27,683 | |
| Total current assets | 384,646 | 415,996 | |
| Property and equipment, net | 14,797 | 15,349 | |
| Operating lease right-of-use assets, net | 24,797 | 22,554 | |
| Deferred contract costs, non-current | 7,013 | 6,439 | |
| Debt issuance costs – line of credit | 339 | 533 | |
| Deferred tax assets, net | 602,500 | 1,344 | |
| Other non-current assets | 3,340 | 3,563 | |
| Intangible assets, net | 30,868 | 26,132 | |
| Goodwill | 70,971 | 45,338 | |
| Long-term investments | 30,301 | 21,495 | |
| Total assets | $ 1,169,572 | $ 558,743 | |
| Liabilities and Stockholders’ Equity | |||
| Current liabilities: | |||
| Accounts payable | $ 2,934 | $ 3,062 | |
| Accrued expenses and other current liabilities | 62,983 | 49,535 | |
| Notes payable, current portion | 2,750 | 2,750 | |
| Operating lease liability, current portion | 8,350 | 6,551 | |
| Tax receivable agreement liability | 35 | 18,894 | |
| Total current liabilities | 77,052 | 80,792 | |
| Notes payable, less current maturities and unamortized debt issuance costs | 43,164 | 45,828 | |
| Operating lease liability, less current portion | 17,655 | 16,948 | |
| Other long-term liabilities | 1,470 | 5,518 | |
| Total liabilities | 139,341 | 149,086 | |
| Commitments and contingencies (Note 11) | |||
| Stockholders’ Equity | |||
| Class A common stock, par value $0.001 per share; 1,500,000,000 shares authorized, 212,857,580 shares issued and outstanding as of December 31, 2024, 127,604,185 shares issued and outstanding as of December 31, 2023 | 213 | 128 | |
| Class B common stock, par value $0.001 per share; 500,000,000 shares authorized, no share issued and outstanding as of December 31, 2024, 111,191 shares issued and outstanding as of December 31, 2023 | — | — | |
| Class C common stock, par value $0.001 per share; 500,000,000 shares authorized, 12,542,110 shares issued and outstanding as of December 31, 2024, 32,684,156 shares issued and outstanding as of December 31, 2023 | 13 | 33 | |
| Class D common stock, par value $0.001 per share; 500,000,000 shares authorized, 22,243,668 shares issued and outstanding as of December 31, 2024, 82,955,977 shares issued and outstanding as of December 31, 2023 | 22 | 83 | |
| Additional paid-in-capital | 725,174 | 532,507 | |
| Accumulated other comprehensive (loss) income | (1,113) | 2,909 | |
| Retained earnings (accumulated deficit) | 283,946 | (181,331) | |
| Total stockholders’ equity attributable to Clearwater Analytics Holdings, Inc. | 1,008,255 | 354,329 | |
| Non-controlling interests | 21,976 | 55,328 | |
| Total stockholders’ equity | 1,030,231 | 409,657 | |
| Total liabilities and stockholders’ equity | $ 1,169,572 | $ 558,743 |
Clearwater Analytics Holdings, Inc.
Consolidated Statements of Operations
(In thousands, except share amounts and per share amounts, unaudited)
| Three Months Ended December 31, |
Year Ended December 31, | ||||||
| 2024 | 2023 | 2024 | 2023 | ||||
| Revenue | $ 126,465 | $ 99,019 | $ 451,803 | $ 368,168 | |||
| Cost of revenue(1) | 33,561 | 28,335 | 122,987 | 107,127 | |||
| Gross profit | 92,904 | 70,684 | 328,816 | 261,041 | |||
| Operating expenses: | |||||||
| Research and development(1) | 40,904 | 33,728 | 150,558 | 123,925 | |||
| Sales and marketing(1) | 17,885 | 16,316 | 67,254 | 60,365 | |||
| General and administrative(1) | 32,896 | 18,050 | 98,770 | 93,496 | |||
| Total operating expenses | 91,685 | 68,094 | 316,582 | 277,786 | |||
| Income (loss) from operations | 1,219 | 2,590 | 12,234 | (16,745) | |||
| Interest income, net | (2,430) | (1,979) | (8,621) | (6,401) | |||
| Tax receivable agreement expense | 41,637 | 8,284 | 53,181 | 14,396 | |||
| Other income, net | (1,150) | (669) | (2,263) | (1,874) | |||
| Loss before income taxes | (36,838) | (3,046) | (30,063) | (22,866) | |||
| Provision for (benefit from) income taxes | (457,143) | 401 | (457,648) | 217 | |||
| Net income (loss) | 420,305 | (3,447) | 427,585 | (23,083) | |||
| Less: Net income (loss) attributable to non-controlling interests | 819 | 739 | 3,207 | (1,456) | |||
| Net income (loss) attributable to Clearwater Analytics Holdings, Inc. | $ 419,486 | $ (4,186) | $ 424,378 | $ (21,627) | |||
| Net earnings (loss) per share attributable to Class A and Class D common stock: | |||||||
| Basic | $ 1.85 | $ (0.02) | $ 1.93 | $ (0.11) | |||
| Diluted | $ 1.63 | $ (0.02) | $ 1.68 | $ (0.11) | |||
| Weighted average shares of Class A and Class D common stock outstanding: | |||||||
| Basic | 226,571,994 | 206,193,802 | 219,316,625 | 199,691,873 | |||
| Diluted | 258,131,701 | 206,193,802 | 254,362,539 | 199,691,873 | |||
(1)Amounts include equity-based compensation as follows:
| Cost of revenue | $ 3,755 | $ 3,378 | $ 13,634 | $ 12,215 | |||
| Operating expenses: | |||||||
| Research and development | 9,326 | 7,346 | 36,093 | 24,739 | |||
| Sales and marketing | 4,885 | 4,622 | 15,304 | 15,843 | |||
| General and administrative | 10,176 | 6,975 | 38,170 | 51,650 | |||
| Total equity-based compensation expense | $ 28,142 | $ 22,321 | $ 103,201 | $ 104,447 |
Clearwater Analytics Holdings, Inc.
Consolidated Statements of Cash Flows
(In thousands, unaudited)
| Three Months Ended
December 31, |
Year Ended December 31, | ||||||
| 2024 | 2023 | 2024 | 2023 | ||||
| OPERATING ACTIVITIES | |||||||
| Net income (loss) | $ 420,305 | $ (3,447) | $ 427,585 | $ (23,083) | |||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 3,451 | 2,593 | 12,181 | 9,929 | |||
| Noncash operating lease cost | 2,341 | 1,952 | 9,221 | 7,619 | |||
| Equity-based compensation | 28,142 | 22,321 | 103,201 | 104,447 | |||
| Amortization of deferred contract acquisition costs | 1,692 | 1,200 | 5,265 | 4,763 | |||
| Amortization of debt issuance costs, included in interest expense | 71 | 71 | 280 | 280 | |||
| Accretion of discount on investments | (452) | (573) | (2,185) | (1,474) | |||
| Deferred tax benefit | (456,956) | (913) | (460,032) | (1,665) | |||
| Realized gain on investments | — | — | (35) | (89) | |||
| Loss on fixed assets disposal | 66 | — | 66 | — | |||
| Changes in operating assets and liabilities, excluding the impact of business acquisitions: | |||||||
| Accounts receivable, net | (5,774) | (434) | (13,648) | (19,298) | |||
| Prepaid expenses and other assets | 3,066 | (3,068) | 5,627 | 1,151 | |||
| Deferred contract acquisition costs | (2,826) | (2,405) | (6,242) | (5,067) | |||
| Accounts payable | (1,317) | (224) | 269 | (115) | |||
| Accrued expenses and other liabilities | 8,044 | 7,081 | 11,627 | 1,204 | |||
| Tax receivable agreement liability | (28,793) | (61) | (18,859) | 6,000 | |||
| Net cash (used in) provided by operating activities | (28,940) | 24,093 | 74,321 | 84,602 | |||
| INVESTING ACTIVITIES | |||||||
| Purchases of property and equipment | (822) | (1,562) | (5,259) | (5,624) | |||
| Purchase of held to maturity investments | — | — | (3,009) | (3,004) | |||
| Purchases of available-for-sale investments | (20,662) | (13,160) | (114,572) | (124,178) | |||
| Proceeds from sale of available-for-sale investments | — | — | — | 5,950 | |||
| Proceeds from maturities of investments | 20,550 | 15,280 | 107,417 | 31,801 | |||
| Acquisition of business, net of cash acquired | — | — | (40,121) | — | |||
| Payment of initial direct costs for operating lease | — | — | (104) | — | |||
| Net cash provided by (used in) investing activities | (934) | 558 | (55,648) | (95,055) | |||
| FINANCING ACTIVITIES | |||||||
| Proceeds from exercise of options | 38 | 274 | 248 | 4,738 | |||
| Taxes paid related to net share settlement of equity awards | (12,638) | (5,895) | (55,301) | (20,784) | |||
| Proceeds from employee stock purchase plan | 1,898 | 1,994 | 4,693 | 4,588 | |||
| Repayments of borrowings | (688) | (688) | (2,750) | (2,749) | |||
| Payment of tax distributions | (3,873) | (2,149) | (3,873) | (2,184) | |||
| Payment of business acquisition holdback liability | (3,905) | (2,900) | (4,685) | (2,900) | |||
| Net cash used in financing activities | (19,168) | (9,364) | (61,668) | (19,291) | |||
| Effect of exchange rate changes on cash and cash equivalents | (2,302) | 813 | (1,420) | 785 | |||
| Change in cash and cash equivalents during the period | (51,344) | 16,100 | (44,415) | (28,959) | |||
| Cash and cash equivalents, beginning of period | 228,694 | 205,665 | 221,765 | 250,724 | |||
| Cash and cash equivalents, end of period | $ 177,350 | $ 221,765 | $ 177,350 | $ 221,765 | |||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||||
| Cash paid for interest | $ 837 | $ 924 | $ 3,464 | $ 3,454 | |||
| Cash paid for income taxes | $ 800 | $ 395 | $ 1,979 | $ 2,432 | |||
| NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||||
| Purchase of property and equipment included in accounts payable and accrued expense | $ 38 | $ 435 | $ 38 | $ 435 | |||
| Tax distributions payable to Continuing Equity Owners included in accrued expenses | $ 23 | $ 2,945 | $ 23 | $ 2,945 | |||
Clearwater Analytics Holdings, Inc.
Reconciliation of Net Loss to Adjusted EBITDA
(In thousands, unaudited)
| Three Months Ended December 31, | |||||||
| 2024 | 2023 | ||||||
| (in thousands, except percentages) | |||||||
| Net income (loss) | $ 420,305 | 332% | $ (3,447) | (3%) | |||
| Adjustments: | |||||||
| Interest income, net | (2,430) | (2%) | (1,979) | (2%) | |||
| Depreciation and amortization | 3,451 | 3% | 2,593 | 3% | |||
| Equity-based compensation expense and related payroll taxes | 30,421 | 24% | 23,660 | 24% | |||
| Tax receivable agreement expense | 41,637 | 33% | 8,284 | 8 % | |||
| Transaction expenses | 6,382 | 5% | 441 | 0% | |||
| Amortization of prepaid management fees and reimbursable expenses | 210 | 0% | 698 | 1 % | |||
| Provision for (benefit from) income taxes | (457,143) | (361%) | 401 | 0% | |||
| Other income, net | (1,150) | (1%) | (669) | (1%) | |||
| Adjusted EBITDA | 41,683 | 33% | 29,982 | 30% | |||
| Revenue | $ 126,465 | 100% | $ 99,019 | 100% | |||
| Year Ended December 31, | |||||||
| 2024 | 2023 | ||||||
| (in thousands, except percentages) | |||||||
| Net income (loss) | $ 427,585 | 95% | $ (23,083) | (6%) | |||
| Adjustments: | |||||||
| Interest income, net | (8,621) | (2%) | (6,401) | (2%) | |||
| Depreciation and amortization | 12,181 | 3% | 9,929 | 3% | |||
| Equity-based compensation expense and related payroll taxes | 110,961 | 25% | 108,078 | 29% | |||
| Tax receivable agreement expense | 53,181 | 12% | 14,396 | 4% | |||
| Transaction expenses | 8,308 | 2% | 2,052 | 1% | |||
| Amortization of prepaid management fees and reimbursable expenses | 1,990 | 0% | 2,592 | 1% | |||
| Provision for (benefit from) income taxes | (457,648) | (101%) | 217 | 0% | |||
| Other income, net | (2,263) | (1%) | (1,874) | (1%) | |||
| Adjusted EBITDA | 145,674 | 32% | 105,906 | 29% | |||
| Revenue | $ 451,803 | 100% | $ 368,168 | 100% | |||
Clearwater Analytics Holdings, Inc.
Reconciliation of Free Cash Flow
(In thousands, unaudited)
| Three Months Ended December 31, | Year Ended December 31, | ||||||
| 2024 | 2023 | 2024 | 2023 | ||||
| Net cash (used in) provided by operating activities | $ (28,940) | $ 24,093 | $ 74,321 | $ 84,602 | |||
| Less: Purchases of property and equipment | 822 | 1,562 | 5,259 | 5,624 | |||
| Free Cash Flow | $ (29,762) | $ 22,531 | $ 69,062 | $ 78,978 | |||
Clearwater Analytics Holdings, Inc.
Reconciliation of Non-GAAP Information
(In thousands, except share amounts and per share amounts, unaudited)
| Three Months Ended December 31, | Year Ended December 31, | ||||||
| 2024 | 2023 | 2024 | 2023 | ||||
| Revenue | $ 126,465 | $ 99,019 | $ 451,803 | $ 368,168 | |||
| Gross profit | $ 92,904 | $ 70,684 | $ 328,816 | $ 261,041 | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 3,963 | 3,411 | 14,546 | 12,734 | |||
| Depreciation and amortization | 2,840 | 2,102 | 10,137 | 7,999 | |||
| Gross profit, non-GAAP | $ 99,707 | $ 76,197 | $ 353,499 | $ 281,774 | |||
| As a percentage of revenue, non-GAAP | 79% | 77% | 78% | 77% | |||
| Cost of Revenue | $ 33,561 | $ 28,335 | $ 122,987 | $ 107,127 | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 3,963 | 3,411 | 14,546 | 12,734 | |||
| Depreciation and amortization | 2,840 | 2,102 | 10,137 | 7,999 | |||
| Cost of revenue, non-GAAP | $ 26,758 | $ 22,822 | $ 98,304 | $ 86,394 | |||
| As a percentage of revenue, non-GAAP | 21% | 23% | 22% | 23% | |||
| Research and development | $ 40,904 | $ 33,728 | $ 150,558 | $ 123,925 | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 11,091 | 7,394 | 41,356 | 25,627 | |||
| Depreciation and amortization | 156 | 258 | 736 | 1,044 | |||
| Research and development, non-GAAP | $ 29,657 | $ 26,076 | $ 108,466 | $ 97,254 | |||
| As a percentage of revenue, non-GAAP | 23% | 26% | 24% | 26% | |||
| Sales and marketing | $ 17,885 | $ 16,316 | $ 67,254 | $ 60,365 | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 5,024 | 4,636 | 16,017 | 16,419 | |||
| Depreciation and amortization | 173 | 148 | 638 | 589 | |||
| Sales and marketing, non-GAAP | $ 12,688 | $ 11,532 | $ 50,599 | $ 43,357 | |||
| As a percentage of revenue, non-GAAP | 10% | 12% | 11% | 12% | |||
| General and administrative | $ 32,896 | $ 18,050 | $ 98,770 | $ 93,496 | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 10,343 | 8,219 | 39,042 | 53,298 | |||
| Depreciation and amortization | 282 | 85 | 670 | 297 | |||
| Amortization of prepaid management fees and reimbursable expenses | 210 | 698 | 1,990 | 2,592 | |||
| Transaction expenses | 6,382 | 441 | 8,308 | 2,052 | |||
| General and administrative, non-GAAP | $ 15,679 | $ 8,607 | $ 48,760 | $ 35,258 | |||
| As a percentage of revenue, non-GAAP | 12% | 9% | 11% | 10% | |||
| Income (loss) from operations | $ 1,219 | $ 2,590 | $ 12,234 | $ (16,745) | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 30,421 | 23,660 | 110,961 | 108,078 | |||
| Depreciation and amortization | 3,451 | 2,593 | 12,181 | 9,929 | |||
| Amortization of prepaid management fees and reimbursable expenses | 210 | 698 | 1,990 | 2,592 | |||
| Transaction expenses | 6,382 | 441 | 8,308 | 2,052 | |||
| Income from operations, non-GAAP | $ 41,683 | $ 29,982 | $ 145,674 | $ 105,906 | |||
| As a percentage of revenue, non-GAAP | 33% | 30% | 32% | 29% | |||
| Net income (loss) | $ 420,305 | $ (3,447) | $ 427,585 | $ (23,083) | |||
| Adjustments: | |||||||
| Equity-based compensation expense and related payroll taxes | 30,421 | 23,660 | 110,961 | 108,078 | |||
| Depreciation and amortization | 3,451 | 2,593 | 12,181 | 9,929 | |||
| Tax receivable agreement expense | 41,637 | 8,284 | 53,181 | 14,396 | |||
| Amortization of prepaid management fees and reimbursable expenses | 210 | 698 | 1,990 | 2,592 | |||
| Transaction expenses | 6,382 | 441 | 8,308 | 2,052 | |||
| Tax impacts of adjustments to net income (loss)(1) | (468,459) | (8,158) | (496,779) | (28,545) | |||
| Net income, non-GAAP | $ 33,947 | $ 24,071 | $ 117,427 | $ 85,419 | |||
| As a percentage of revenue, non-GAAP | 27% | 24% | 26% | 23% | |||
| Net income per share – basic, non-GAAP | $ 0.15 | $ 0.12 | $ 0.54 | $ 0.43 | |||
| Net income per share – diluted, non-GAAP | $ 0.13 | $ 0.10 | $ 0.46 | $ 0.33 | |||
| Weighted-average common shares outstanding – basic | 226,571,994 | 206,193,802 | 219,316,625 | 199,691,873 | |||
| Weighted-average common shares outstanding – diluted | 258,131,701 | 252,215,606 | 254,362,539 | 255,750,590 | |||
(1) The non-GAAP effective tax rate was 25% for the three months and year ended December 31, 2024 and 2023, respectively, and has been used to adjust the provision for income taxes for non-GAAP net income and non-GAAP basic and diluted net income per share. The Company excludes income tax benefits from discrete activities, including the income tax benefit related to the release of the US federal state valuation allowance, because of their nonrecurring nature.